Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alain H Rook

Showing results (41-50 of 98) with videos related to

Pageof 10
Sort By:
Journal of the American Academy of Dermatology|March 21, 2006
Posttransplantation lymphoproliferative disease with features of lymphomatoid granulomatosis in a lung transplant patientEun Ji Kwon, Kenneth A Katz, Karla S Draft, et al.
Clinical Immunology (Orlando, Fla.)|March 13, 2015
Improved pruritus correlates with lower levels of IL-31 in CTCL patients under different therapeutic modalitiesFiliberto Cedeno-Laurent, Elisha M Singer, Maria Wysocka, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|June 25, 2002
New biologic agents for the treatment of cutaneous T-cell lymphomaCarmela C Vittorio, Jacqueline M Junkins-Hopkins, Karen S McGinnis, et al.
Advances in Dermatology|January 17, 2003
Cytokines and other biologic agents as immunotherapeutics for cutaneous T-cell lymphomaAlain H Rook, Jacqueline M Junkins-Hopkins, Karen S McGinnis, et al.
Blood|October 18, 2002
Sézary syndrome patients demonstrate a defect in dendritic cell populations: effects of CD40 ligand and treatment with GM-CSF on dendritic cell numbers and the production of cytokinesMaria Wysocka, Mohamed H Zaki, Lars E French, et al.
Journal of Cutaneous Pathology|January 14, 2017
Gain of CD26 expression on the malignant T-cells in relapsed erythrodermic leukemic mycosis fungoidesFiliberto Cedeno-Laurent, Maria Wysocka, Amrom E Obstfeld, et al.
Blood Advances|September 2, 2022
TCRvβ-CART therapy mediates high-precision targeting of malignant T-cell clonesLauren C Shaw, Mathilde Poussin, Alba Rodriguez-Garcia, et al.
Cutis|October 26, 2020
Cutaneous T-cell lymphoma and concomitant atopic dermatitis responding to dupilumabNicholas K Mollanazar, Kevin T Savage, Bobak T Pousti, et al.
Journal of the American Academy of Dermatology|February 6, 2008
Total skin electron beam therapy may be associated with improvement of peripheral blood disease in Sézary syndromeCamille E Introcaso, Bizhan Micaily, Stephen K Richardson, et al.
Dermatologic Therapy|April 28, 2022
Management of relapsed cutaneous T-Cell lymphoma following allogeneic hematopoietic stem cell transplantation: Review with representative patient caseDavid M Weiner, Daniel J Lewis, Natalie G Spaccarelli, et al.
Pageof 10

Showing results (41-50 of 98) with videos related to

Sort By:
Pageof 10
Journal of the American Academy of Dermatology|March 21, 2006
Posttransplantation lymphoproliferative disease with features of lymphomatoid granulomatosis in a lung transplant patientEun Ji Kwon, Kenneth A Katz, Karla S Draft, et al.
Clinical Immunology (Orlando, Fla.)|March 13, 2015
Improved pruritus correlates with lower levels of IL-31 in CTCL patients under different therapeutic modalitiesFiliberto Cedeno-Laurent, Elisha M Singer, Maria Wysocka, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|June 25, 2002
New biologic agents for the treatment of cutaneous T-cell lymphomaCarmela C Vittorio, Jacqueline M Junkins-Hopkins, Karen S McGinnis, et al.
Advances in Dermatology|January 17, 2003
Cytokines and other biologic agents as immunotherapeutics for cutaneous T-cell lymphomaAlain H Rook, Jacqueline M Junkins-Hopkins, Karen S McGinnis, et al.
Blood|October 18, 2002
Sézary syndrome patients demonstrate a defect in dendritic cell populations: effects of CD40 ligand and treatment with GM-CSF on dendritic cell numbers and the production of cytokinesMaria Wysocka, Mohamed H Zaki, Lars E French, et al.
Journal of Cutaneous Pathology|January 14, 2017
Gain of CD26 expression on the malignant T-cells in relapsed erythrodermic leukemic mycosis fungoidesFiliberto Cedeno-Laurent, Maria Wysocka, Amrom E Obstfeld, et al.
Blood Advances|September 2, 2022
TCRvβ-CART therapy mediates high-precision targeting of malignant T-cell clonesLauren C Shaw, Mathilde Poussin, Alba Rodriguez-Garcia, et al.
Cutis|October 26, 2020
Cutaneous T-cell lymphoma and concomitant atopic dermatitis responding to dupilumabNicholas K Mollanazar, Kevin T Savage, Bobak T Pousti, et al.
Journal of the American Academy of Dermatology|February 6, 2008
Total skin electron beam therapy may be associated with improvement of peripheral blood disease in Sézary syndromeCamille E Introcaso, Bizhan Micaily, Stephen K Richardson, et al.
Dermatologic Therapy|April 28, 2022
Management of relapsed cutaneous T-Cell lymphoma following allogeneic hematopoietic stem cell transplantation: Review with representative patient caseDavid M Weiner, Daniel J Lewis, Natalie G Spaccarelli, et al.
Pageof 10